Truncations of apolipoprotein (apo) B shorter than 3200 amino acids (3
200/4536=apoB-70) do not possess the LDL receptor-recognition domain a
nd are not recognized by altered cells with normally functioning LDL r
eceptors. To ascertain which organs remove such truncated apoB-contain
ing particles, we isolated apoB-31-, apoB-38.9-, and apoB-43.7-contain
ing particles from plasmas of familial hypobetalipoproteinemia heteroz
ygous humans by a combination of sequential ultracentrifugation and pr
eparative electrophoresis, Particles with labeled I-125- or I-131-dila
ctitol tyramine (I-DLT), were injected into New Zealand White rabbits,
along with I-DLT-apoB-100-containing LDLs, and the decay of I-125- an
d I-131-TCA-precipitated counts was followed over 24 hours. At the end
of 24 hours, rabbits were anesthetized and their bodies perfused. Org
ans were removed and homogenized, and TCA-precipitable counts determin
ed, Fractional catabolic rates of apoB truncation particles were two t
o five times greater than those of apoB-100 LDLs. ApoB truncations acc
umulated in adrenals at one fifth the rates of apoB-100 LDL, compatibl
e with the functional absences of LDL receptor-recognition domains in
truncated apoBs. The major organ of uptake for apoB-100-LDLs was the l
iver, whereas truncation particles were readily removed by the kidney
(kidney. liver uptake ratios were 0.10 to 0.30 for apoB-100 LDLs and 1
.03 to 3.77 for truncations). Spleens accumulated little of either apo
B-100 or truncation particles, suggesting particles were not ''damaged
'' or aggregated. Thus, the absence of > 56% of the carboxyl end of ap
oB-100 increases the plasma clearance and redirects the organ uptake o
f the apoB truncation-containing lipoproteins from liver to kidney.